Approval · Notice of Compliance 364 · 2002
ZINACEF: Notice of Compliance 364
Issued May 8, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 364
- Date
- May 8, 2002
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antibiotic
Products in this notice
Medicinal ingredients
- CEFUROXIME SODIUM 750 MG per VIAL
- CEFUROXIME SODIUM 1.5 G per VIAL
- CEFUROXIME SODIUM 7.5 G per VIAL